Here are six points:
1. The fourth quarter EPS hit $1.27, an increase of 9.5 percent year-over-year.
2. The company’s full-year adjusted earnings hit $4.37 per share, a 2 percent increase from the same time last year.
3. Medtronic’s worldwide revenues in the fourth quarter grossed $7.57 billion, an increase of 6 percent year-over-year. The top line surpassed Zacks Consensus Estimate of $7.48 billion.
4. Full-year 2016 total revenue reached $28.83 billion, a 7 percent increase from last year. The Zacks Consensus Estimate for full-year 2016 total revenue fell short at $28.75 billion.
5. Medtronic’s U.S. sales increased 4 percent year-over-year to $4.22 billion in the fourth quarter.
6. Zacks concluded the company ended fiscal 2016 strongly, but Medtronic will face significant currency headwinds in fiscal 2017.
More articles on devices:
Aurora Spine completes non-brokered private placement of 2.53M common shares: 4 key notes
Camber Capital Management’s stake in NuVasive totals $79.7M: 3 points
Tyber Medical expands to Australia: 3 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
